These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 1711588)
1. The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia. Coplen DE; Andriole GL; Yuan JJ; Catalona WJ J Urol; 1991 Jul; 146(1):75-7. PubMed ID: 1711588 [TBL] [Abstract][Full Text] [Related]
2. Transrectal ultrasound imaging and ultrasound guided prostate biopsies in the detection of residual carcinoma in clinical stage A carcinoma of the prostate. Terris MK; McNeal JE; Stamey TA J Urol; 1992 Mar; 147(3 Pt 2):864-9. PubMed ID: 1371562 [TBL] [Abstract][Full Text] [Related]
3. [Importance of specific prostatic antigen to prostatic volume ratio in the selection of patients for ultrasonography-guided biopsy of the prostate]. Veneziano S; Pavlica P; Querzè R; Viglietta G; Trenta A Radiol Med; 1991 Jun; 81(6):857-60. PubMed ID: 1713333 [TBL] [Abstract][Full Text] [Related]
4. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma. Bretton PR; Evans WP; Borden JD; Castellanos RD Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040 [TBL] [Abstract][Full Text] [Related]
5. Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum. Seaman EK; Sawczuk IS; Fatal M; Olsson CA; Shabsigh R Urology; 1996 Mar; 47(3):353-5. PubMed ID: 8633401 [TBL] [Abstract][Full Text] [Related]
6. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. Ornstein DK; Rao GS; Smith DS; Andriole GL J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591 [TBL] [Abstract][Full Text] [Related]
7. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer. Terris MK; Freiha FS; McNeal JE; Stamey TA J Urol; 1991 Jul; 146(1):78-83; discussion 83-4. PubMed ID: 1711589 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer. Smart R N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211 [TBL] [Abstract][Full Text] [Related]
10. Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer. Lee F; Littrup PJ; Loft-Christensen L; Kelly BS; McHugh TA; Siders DB; Mitchell AE; Newby JE Cancer; 1992 Jul; 70(1 Suppl):211-20. PubMed ID: 1376190 [TBL] [Abstract][Full Text] [Related]
11. Volume of normal prostate, of prostate cancer, and of benign prostatic hyperplasia: are correlations with prostate specific antigen clinically useful? Clements R; Penney MD; Etherington RJ; Griffiths GJ; Hughes H; Peeling WB Prostate Suppl; 1992; 4():51-7. PubMed ID: 1374178 [TBL] [Abstract][Full Text] [Related]
12. [Transrectal ultrasound of the prostate]. Ramírez-Arias JL; González-Roman A; Cal y Mayor-Villalobos M; Barreda-Reyes LM Gac Med Mex; 1991; 127(3):241-6; discussion 246-7. PubMed ID: 1724768 [TBL] [Abstract][Full Text] [Related]
13. [Endosonography of the prostate]. Hammerer P Urologe A; 1991 Nov; 30(6):370-7. PubMed ID: 1722920 [TBL] [Abstract][Full Text] [Related]
14. Results of transrectal ultrasound-guided biopsies and clinical significance of Japanese prostate cancer. Egawa S; Matsumoto K; Yoshida K; Iwamura M; Kuwao S; Koshiba K Jpn J Clin Oncol; 1998 Nov; 28(11):666-72. PubMed ID: 9861233 [TBL] [Abstract][Full Text] [Related]
15. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. Terris MK; McNeal JE; Stamey TA J Urol; 1992 Sep; 148(3):829-32. PubMed ID: 1380991 [TBL] [Abstract][Full Text] [Related]
16. Advantage of systematic random ultrasound-guided biopsies, measurement of serum prostate-specific antigen level and determination of prostate volume in the early diagnosis of prostate cancer. Billebaud T; Villers A; Astier L; Boccon-Gibod L; Dauge MC; Sibert A; Baron JC; Delmas V; Boccon-Gibod L Eur Urol; 1992; 21(1):6-14. PubMed ID: 1376693 [TBL] [Abstract][Full Text] [Related]
17. Influence of prostate volume and percent free prostate specific antigen on prostate cancer detection in men with a total prostate specific antigen of 2.6 to 10.0 ng/ml. Bruno JJ; Armenakas NA; Fracchia JA J Urol; 2007 May; 177(5):1741-4. PubMed ID: 17437802 [TBL] [Abstract][Full Text] [Related]
18. Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: usefulness in diagnosis of prostate cancer. Veneziano S; Pavlica P; Querzé R; Nanni G; Lalanne MG; Vecchi F Eur Urol; 1990; 18(2):112-6. PubMed ID: 1699766 [TBL] [Abstract][Full Text] [Related]
19. Factors influencing the degree of enhancement of prostate cancer on contrast-enhanced transrectal ultrasonography: correlation with biopsy and radical prostatectomy specimens. Jiang J; Chen YQ; Zhu YK; Yao XH; Qi J Br J Radiol; 2012 Nov; 85(1019):e979-86. PubMed ID: 22700257 [TBL] [Abstract][Full Text] [Related]
20. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients. Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]